id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02514915
|
,,113:121:treatment
|
Patients will have no more than 4 distinct lesions within the brain. At least 1 lesion has been recommended for surgical removal based on size, symptomology, or regional mass effect on the brain
| 3
|
[
"Patients",
"will",
"have",
"no",
"more",
"than",
"4",
"distinct",
"lesions",
"within",
"the",
"brain",
".",
"At",
"least",
"1",
"lesion",
"has",
"been",
"recommended",
"for",
"surgical",
"removal",
"based",
"on",
"size",
",",
"symptomology",
",",
"or",
"regional",
"mass",
"effect",
"on",
"the",
"brain"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02271919
|
9:23:treatment,,45:55:treatment,57:66:treatment,68:73:treatment,75:103:treatment
|
smoking cessation meds (last 7 days), i.e., Wellbutrin, Bupropion, Zyban, nicotine replacement therapy
| 3
|
[
"smoking",
"cessation",
"meds",
"(",
"last",
"7",
"days",
")",
",",
"i.e.",
",",
"Wellbutrin",
",",
"Bupropion",
",",
"Zyban",
",",
"nicotine",
"replacement",
"therapy"
] |
[
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
1,
1
] |
NCT01811368
|
39:41:chronic_disease,43:45:chronic_disease,47:49:chronic_disease,53:72:chronic_disease
|
Patients who had anything less than a CR (PR, SD or progressive disease) to their last salvage regimen
| 3
|
[
"Patients",
"who",
"had",
"anything",
"less",
"than",
"a",
"CR",
"(",
"PR",
",",
"SD",
"or",
"progressive",
"disease",
")",
"to",
"their",
"last",
"salvage",
"regimen"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT01962415
|
15:29:chronic_disease
|
patients with sickle disease
| 3
|
[
"patients",
"with",
"sickle",
"disease"
] |
[
0,
0,
2,
2
] |
NCT00737893
|
1:22:chronic_disease
|
myocardial infarction
| 3
|
[
"myocardial",
"infarction"
] |
[
2,
2
] |
NCT02016781
|
1:15:treatment
|
allogeneic HCT
| 3
|
[
"allogeneic",
"HCT"
] |
[
1,
1
] |
NCT01245712
|
56:78:chronic_disease,80:95:chronic_disease,97:112:chronic_disease,117:139:chronic_disease,236:241:cancer
|
Palpable or radiographically suspicious ipsilateral or contralateral axillary, supraclavicular, infraclavicular, or internal mammary nodes at time of enrollment unless there is histologic confirmation that these nodes are negative for tumor
| 3
|
[
"Palpable",
"or",
"radiographically",
"suspicious",
"ipsilateral",
"or",
"contralateral",
"axillary",
",",
"supraclavicular",
",",
"infraclavicular",
",",
"or",
"internal",
"mammary",
"nodes",
"at",
"time",
"of",
"enrollment",
"unless",
"there",
"is",
"histologic",
"confirmation",
"that",
"these",
"nodes",
"are",
"negative",
"for",
"tumor"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT03179605
|
22:31:treatment,48:54:cancer,,99:110:cancer,115:140:cancer
|
Subject has received treatment for any type of cancer within 5 years of the Baseline Visit except skin cancer and cervical cancer (in situ) are allowed if at least 1 year before the Baseline Visit
| 3
|
[
"Subject",
"has",
"received",
"treatment",
"for",
"any",
"type",
"of",
"cancer",
"within",
"5",
"years",
"of",
"the",
"Baseline",
"Visit",
"except",
"skin",
"cancer",
"and",
"cervical",
"cancer",
"(",
"in",
"situ",
")",
"are",
"allowed",
"if",
"at",
"least",
"1",
"year",
"before",
"the",
"Baseline",
"Visit"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01419561
|
1:16:chronic_disease,,
|
Hypoalbuminemia (albumin<3.5g/dL)
| 3
|
[
"Hypoalbuminemia",
"(",
"albumin",
"<",
"3.5g/dL",
")"
] |
[
2,
0,
0,
0,
0,
0
] |
NCT01459107
|
54:74:treatment
|
Personally identifiable tattoo (i.e., donor name) on potential transplant
| 3
|
[
"Personally",
"identifiable",
"tattoo",
"(",
"i.e.",
",",
"donor",
"name",
")",
"on",
"potential",
"transplant"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02475707
|
12:22:treatment,77:97:treatment,77:98:treatment,151:169:treatment
|
Donors for allogeneic (i.e. HLA matched or mismatched related or unrelated) stem cell transplants who have fulfilled eligibility for and consented to stem cell donation as per the stem cell transplant program's standard operating procedures
| 3
|
[
"Donors",
"for",
"allogeneic",
"(",
"i.e",
".",
"HLA",
"matched",
"or",
"mismatched",
"related",
"or",
"unrelated",
")",
"stem",
"cell",
"transplants",
"who",
"have",
"fulfilled",
"eligibility",
"for",
"and",
"consented",
"to",
"stem",
"cell",
"donation",
"as",
"per",
"the",
"stem",
"cell",
"transplant",
"program",
"'s",
"standard",
"operating",
"procedures"
] |
[
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02347995
|
,85:92:chronic_disease
|
recent hospitalization (less than 3 months prior to study entry) for severe medical disease
| 3
|
[
"recent",
"hospitalization",
"(",
"less",
"than",
"3",
"months",
"prior",
"to",
"study",
"entry",
")",
"for",
"severe",
"medical",
"disease"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT01684397
|
1:7:treatment,25:64:cancer,70:80:cancer
|
Biopsy/pathology-proven clear cell renal cell carcinoma (CCRCC) with metastases
| 3
|
[
"Biopsy/pathology-proven",
"clear",
"cell",
"renal",
"cell",
"carcinoma",
"(",
"CCRCC",
")",
"with",
"metastases"
] |
[
1,
3,
3,
3,
3,
3,
3,
0,
0,
0,
3
] |
NCT02544373
|
1:10:chronic_disease,11:22:chronic_disease,26:46:chronic_disease
|
Physical, psychiatric or cognitive impairment that prevents informed consent, PSG, PAP use, or reliable longitudinal follow-up
| 3
|
[
"Physical",
",",
"psychiatric",
"or",
"cognitive",
"impairment",
"that",
"prevents",
"informed",
"consent",
",",
"PSG",
",",
"PAP",
"use",
",",
"or",
"reliable",
"longitudinal",
"follow-up"
] |
[
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2
] |
NCT02134392
|
11:27:chronic_disease,
|
Recurrent c-diff infection (three or more occurrences)
| 3
|
[
"Recurrent",
"c-diff",
"infection",
"(",
"three",
"or",
"more",
"occurrences",
")"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT01326715
|
12:21:allergy_name
|
Allergy to manganese
| 3
|
[
"Allergy",
"to",
"manganese"
] |
[
0,
0,
4
] |
NCT01849146
|
15:30:treatment,32:40:treatment,80:87:treatment,89:93:treatment
|
may not be on anti-coagulants (warfarin, etc.) other than low-molecular weight heparin (LMWH)
| 3
|
[
"may",
"not",
"be",
"on",
"anti-coagulants",
"(",
"warfarin",
",",
"etc",
".",
")",
"other",
"than",
"low-molecular",
"weight",
"heparin",
"(",
"LMWH",
")"
] |
[
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0
] |
NCT02780401
|
1:42:treatment
|
Fluorescence in situ hybridization (FISH) negative
| 3
|
[
"Fluorescence",
"in",
"situ",
"hybridization",
"(",
"FISH",
")",
"negative"
] |
[
1,
1,
1,
1,
1,
0,
0,
0
] |
NCT01895881
|
1:26:chronic_disease,28:39:chronic_disease,44:54:cancer
|
Endometrial proliferation, hyperplasia, or malignancy at screening
| 3
|
[
"Endometrial",
"proliferation",
",",
"hyperplasia",
",",
"or",
"malignancy",
"at",
"screening"
] |
[
2,
2,
0,
2,
0,
0,
3,
0,
0
] |
NCT02000115
|
1:24:chronic_disease,35:52:treatment,56:83:treatment
|
Hemodynamic instability requiring inotropic support or mechanical heart assistance
| 3
|
[
"Hemodynamic",
"instability",
"requiring",
"inotropic",
"support",
"or",
"mechanical",
"heart",
"assistance"
] |
[
2,
2,
0,
1,
1,
0,
1,
1,
1
] |
NCT02876510
|
32:48:allergy_name,50:61:allergy_name,65:69:allergy_name
|
History of hypersensitivity to cyclophosphamide, fludarabine or IL-2
| 3
|
[
"History",
"of",
"hypersensitivity",
"to",
"cyclophosphamide",
",",
"fludarabine",
"or",
"IL-2"
] |
[
0,
0,
0,
0,
4,
0,
4,
0,
4
] |
NCT02570256
|
8:18:chronic_disease,
|
severe spasticity (Modified Ashworth of 4) preventing movement
| 3
|
[
"severe",
"spasticity",
"(",
"Modified",
"Ashworth",
"of",
"4",
")",
"preventing",
"movement"
] |
[
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02496663
|
8:14:treatment,18:23:cancer,56:64:chronic_disease,88:98:chronic_disease,159:168:treatment,266:276:chronic_disease
|
have a biopsy of tumor taken after progression on last EGFR-TKI that indicates loss of EGFR-T790M (EGFR-T790M negative) confirmed by central testing prior to treatment (if EGFR-T790M status is unknown, patients may consent for trial and for biopsy, and testing for EGFR T790M will be performed as part of initial biopsy for trial)
| 3
|
[
"have",
"a",
"biopsy",
"of",
"tumor",
"taken",
"after",
"progression",
"on",
"last",
"EGFR-TKI",
"that",
"indicates",
"loss",
"of",
"EGFR-T790M",
"(",
"EGFR-T790M",
"negative",
")",
"confirmed",
"by",
"central",
"testing",
"prior",
"to",
"treatment",
"(",
"if",
"EGFR-T790M",
"status",
"is",
"unknown",
",",
"patients",
"may",
"consent",
"for",
"trial",
"and",
"for",
"biopsy",
",",
"and",
"testing",
"for",
"EGFR",
"T790M",
"will",
"be",
"performed",
"as",
"part",
"of",
"initial",
"biopsy",
"for",
"trial",
")"
] |
[
0,
0,
1,
0,
3,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01562626
|
11:17:chronic_disease,
|
new onset angina (i.e., began within the last 3 months)
| 3
|
[
"new",
"onset",
"angina",
"(",
"i.e.",
",",
"began",
"within",
"the",
"last",
"3",
"months",
")"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02861950
|
1:36:chronic_disease
|
proximal or penoscrotal hypospadias
| 3
|
[
"proximal",
"or",
"penoscrotal",
"hypospadias"
] |
[
2,
2,
2,
2
] |
NCT03090672
|
4:22:chronic_disease
|
No systemic disorders which, in the opinion of the principal investigators or provider, would disqualify from being safely able to undergo needed procedures
| 3
|
[
"No",
"systemic",
"disorders",
"which",
",",
"in",
"the",
"opinion",
"of",
"the",
"principal",
"investigators",
"or",
"provider",
",",
"would",
"disqualify",
"from",
"being",
"safely",
"able",
"to",
"undergo",
"needed",
"procedures"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02321501
|
30:59:chronic_disease,61:74:chronic_disease,83:92:chronic_disease,94:121:chronic_disease,127:144:chronic_disease,164:181:chronic_disease,164:175:chronic_disease,263:280:chronic_disease
|
active (acute or chronic) or uncontrolled severe infection, liver disease such as cirrhosis, decompensated liver disease, and chronic hepatitis (i.e. quantifiable hepatitis B virus test [HBV-DNA] and/or positive hepatitis B surface antigen [HbsAg], quantifiable hepatitis C virus test [HCV-RNA])
| 3
|
[
"active",
"(",
"acute",
"or",
"chronic",
")",
"or",
"uncontrolled",
"severe",
"infection",
",",
"liver",
"disease",
"such",
"as",
"cirrhosis",
",",
"decompensated",
"liver",
"disease",
",",
"and",
"chronic",
"hepatitis",
"(",
"i.e",
".",
"quantifiable",
"hepatitis",
"B",
"virus",
"test",
"[",
"HBV-DNA",
"]",
"and/or",
"positive",
"hepatitis",
"B",
"surface",
"antigen",
"[",
"HbsAg",
"]",
",",
"quantifiable",
"hepatitis",
"C",
"virus",
"test",
"[",
"HCV-RNA",
"]",
")"
] |
[
0,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
0,
2,
2,
2,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02339233
|
12:46:treatment
|
no current anti-spasticity medication regimen
| 3
|
[
"no",
"current",
"anti-spasticity",
"medication",
"regimen"
] |
[
0,
0,
1,
1,
1
] |
NCT02003222
|
23:48:chronic_disease,105:112:treatment,120:140:chronic_disease,
|
Patient must not have intercurrent organ damage or medical problems that will jeopardize the outcome of therapy (i.e., psychiatric disorder, drug abuse, pregnancy)
| 3
|
[
"Patient",
"must",
"not",
"have",
"intercurrent",
"organ",
"damage",
"or",
"medical",
"problems",
"that",
"will",
"jeopardize",
"the",
"outcome",
"of",
"therapy",
"(",
"i.e.",
",",
"psychiatric",
"disorder",
",",
"drug",
"abuse",
",",
"pregnancy",
")"
] |
[
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02451982
|
59:64:chronic_disease,66:71:chronic_disease,73:79:chronic_disease,81:85:chronic_disease,87:99:chronic_disease,101:107:chronic_disease,109:122:chronic_disease,132:150:chronic_disease
|
Currently have or have history of certain study-specified heart, liver, kidney, lung, neurological, immune, psychological or other medical conditions
| 3
|
[
"Currently",
"have",
"or",
"have",
"history",
"of",
"certain",
"study-specified",
"heart",
",",
"liver",
",",
"kidney",
",",
"lung",
",",
"neurological",
",",
"immune",
",",
"psychological",
"or",
"other",
"medical",
"conditions"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
0,
2,
0,
2,
0,
2,
0,
2,
0,
2,
0,
0,
2,
2
] |
NCT02370693
|
1:20:chronic_disease
|
Psychiatric illness likely to interfere with participation in this clinical study
| 3
|
[
"Psychiatric",
"illness",
"likely",
"to",
"interfere",
"with",
"participation",
"in",
"this",
"clinical",
"study"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01220583
|
10:29:cancer,38:66:cancer,,127:158:cancer,160:171:cancer,176:182:cancer
|
No prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years (for example, carcinoma in situ of the breast, oral cavity, or cervix are all permissible)
| 3
|
[
"No",
"prior",
"invasive",
"malignancy",
"(",
"except",
"non-melanomatous",
"skin",
"cancer",
")",
"unless",
"disease",
"free",
"for",
"a",
"minimum",
"of",
"3",
"years",
"(",
"for",
"example",
",",
"carcinoma",
"in",
"situ",
"of",
"the",
"breast",
",",
"oral",
"cavity",
",",
"or",
"cervix",
"are",
"all",
"permissible",
")"
] |
[
0,
0,
3,
3,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
3,
3,
0,
0,
3,
0,
0,
0,
0
] |
NCT03027115
|
34:55:treatment
|
Presenting with hernia requiring surgical intervention
| 3
|
[
"Presenting",
"with",
"hernia",
"requiring",
"surgical",
"intervention"
] |
[
0,
0,
0,
0,
1,
1
] |
NCT02352025
|
33:51:treatment,61:74:cancer,85:91:treatment,
|
Patients must with eligible for surgical resection of their breast cancer or repeat biopsy after completing 14 days of treatment
| 3
|
[
"Patients",
"must",
"with",
"eligible",
"for",
"surgical",
"resection",
"of",
"their",
"breast",
"cancer",
"or",
"repeat",
"biopsy",
"after",
"completing",
"14",
"days",
"of",
"treatment"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
3,
3,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02433210
|
32:39:treatment
|
Patients which cannot tolerate Heparin
| 3
|
[
"Patients",
"which",
"can",
"not",
"tolerate",
"Heparin"
] |
[
0,
0,
0,
0,
0,
1
] |
NCT02581215
|
13:37:chronic_disease,24:37:chronic_disease,39:63:chronic_disease,87:116:chronic_disease,,,
|
Symptomatic congestive heart failure, unstable angina pectoris, symptomatic or poorly controlled cardiac arrhythmia. Symptomatic heart failure per New York Heart Association (NYHA) Class II-IV
| 3
|
[
"Symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"symptomatic",
"or",
"poorly",
"controlled",
"cardiac",
"arrhythmia",
".",
"Symptomatic",
"heart",
"failure",
"per",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"Class",
"II-IV"
] |
[
0,
2,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03008174
|
1:18:treatment
|
Open tracheostomy
| 3
|
[
"Open",
"tracheostomy"
] |
[
1,
1
] |
NCT02512497
|
20:29:chronic_disease,,,43:57:chronic_disease,75:94:chronic_disease,83:94:chronic_disease
|
Evidence of either cirrhosis or stage 3-4 liver fibrosis in patients with chronic hepatitis C or positive hepatitis C serology
| 3
|
[
"Evidence",
"of",
"either",
"cirrhosis",
"or",
"stage",
"3-4",
"liver",
"fibrosis",
"in",
"patients",
"with",
"chronic",
"hepatitis",
"C",
"or",
"positive",
"hepatitis",
"C",
"serology"
] |
[
0,
0,
0,
2,
0,
0,
0,
2,
2,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02573493
|
1:13:cancer,40:50:cancer,,,154:189:cancer,191:228:cancer,230:258:cancer,260:291:cancer,331:346:cancer,
|
malignancies with a negligible risk of metastasis or death (e.g., expected 5-year OS > 90%) that were treated with an expected curative outcome, such as squamous cell carcinoma of the skin, in-situ carcinoma of the cervix uteri, non-melanomatous skin cancer, carcinoma in situ of the breast, or incidental histological finding of prostate cancer (TNM stage of T1a or T1b
| 3
|
[
"malignancies",
"with",
"a",
"negligible",
"risk",
"of",
"metastasis",
"or",
"death",
"(",
"e.g.",
",",
"expected",
"5-year",
"OS",
">",
"90",
"%",
")",
"that",
"were",
"treated",
"with",
"an",
"expected",
"curative",
"outcome",
",",
"such",
"as",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
",",
"in-situ",
"carcinoma",
"of",
"the",
"cervix",
"uteri",
",",
"non-melanomatous",
"skin",
"cancer",
",",
"carcinoma",
"in",
"situ",
"of",
"the",
"breast",
",",
"or",
"incidental",
"histological",
"finding",
"of",
"prostate",
"cancer",
"(",
"TNM",
"stage",
"of",
"T1a",
"or",
"T1b"
] |
[
3,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02138214
|
30:68:cancer
|
No pre-operative evidence of cervical lymph node metastases on neck ultrasound (randomization arms only)
| 3
|
[
"No",
"pre-operative",
"evidence",
"of",
"cervical",
"lymph",
"node",
"metastases",
"on",
"neck",
"ultrasound",
"(",
"randomization",
"arms",
"only",
")"
] |
[
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT03131037
|
8:21:chronic_disease,39:48:chronic_disease,52:68:chronic_disease
|
Active liver disease, including known cirrhosis or active hepatitis
| 3
|
[
"Active",
"liver",
"disease",
",",
"including",
"known",
"cirrhosis",
"or",
"active",
"hepatitis"
] |
[
0,
2,
2,
0,
0,
0,
2,
0,
2,
2
] |
NCT01841333
|
1:25:chronic_disease
|
Unstable angina pectoris
| 3
|
[
"Unstable",
"angina",
"pectoris"
] |
[
2,
2,
2
] |
NCT01185210
|
1:11:treatment,19:31:treatment,33:48:treatment,50:67:treatment,69:81:treatment
|
GI surgery except appendectomy, cholecystectomy, caesarean section, hysterectomy
| 3
|
[
"GI",
"surgery",
"except",
"appendectomy",
",",
"cholecystectomy",
",",
"caesarean",
"section",
",",
"hysterectomy"
] |
[
1,
1,
0,
1,
0,
1,
0,
1,
1,
0,
1
] |
NCT02178566
|
1:22:chronic_disease,
|
myocardial infarction within 3 months prior to screening
| 3
|
[
"myocardial",
"infarction",
"within",
"3",
"months",
"prior",
"to",
"screening"
] |
[
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02169089
|
24:48:chronic_disease
|
History of any severe, life-threatening disease
| 3
|
[
"History",
"of",
"any",
"severe",
",",
"life-threatening",
"disease"
] |
[
0,
0,
0,
0,
0,
2,
2
] |
NCT02979327
|
7:26:chronic_disease
|
Known lactose intolerance (due to presence of lactose in the prepared medication)
| 3
|
[
"Known",
"lactose",
"intolerance",
"(",
"due",
"to",
"presence",
"of",
"lactose",
"in",
"the",
"prepared",
"medication",
")"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02263729
|
28:31:treatment
|
Have contraindications for MRI
| 3
|
[
"Have",
"contraindications",
"for",
"MRI"
] |
[
0,
0,
0,
1
] |
NCT02421315
|
1:24:chronic_disease
|
Tourette's/Tic Disorder
| 3
|
[
"Tourette's/Tic",
"Disorder"
] |
[
2,
2
] |
NCT02600897
|
5:17:treatment,38:57:treatment,62:101:treatment,156:174:treatment
|
For obinutuzumab in combination with polatuzumab vedotin and lenalidomide (G + Pola + Len) treatment group: R/R FL after treatment with at least one prior chemoimmunotherapy regimen that included an anti-CD20 monoclonal antibody and for which no other more appropriate treatment option exists as determined by the investigator
| 3
|
[
"For",
"obinutuzumab",
"in",
"combination",
"with",
"polatuzumab",
"vedotin",
"and",
"lenalidomide",
"(",
"G",
"+",
"Pola",
"+",
"Len",
")",
"treatment",
"group",
":",
"R/R",
"FL",
"after",
"treatment",
"with",
"at",
"least",
"one",
"prior",
"chemoimmunotherapy",
"regimen",
"that",
"included",
"an",
"anti-CD20",
"monoclonal",
"antibody",
"and",
"for",
"which",
"no",
"other",
"more",
"appropriate",
"treatment",
"option",
"exists",
"as",
"determined",
"by",
"the",
"investigator"
] |
[
0,
1,
0,
0,
0,
1,
1,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02236013
|
20:36:cancer,48:51:cancer,55:85:cancer
|
Subject has active malignant tumors other than AML or myelodysplastic syndrome (MDS)
| 3
|
[
"Subject",
"has",
"active",
"malignant",
"tumors",
"other",
"than",
"AML",
"or",
"myelodysplastic",
"syndrome",
"(",
"MDS",
")"
] |
[
0,
0,
0,
3,
3,
0,
0,
3,
0,
3,
3,
3,
0,
0
] |
NCT01589263
|
1:19:chronic_disease
|
Overactive bladder without obstructive symptoms (i.e. decrease in force of stream, hesitancy, intermittency, post-void dribbling)
| 3
|
[
"Overactive",
"bladder",
"without",
"obstructive",
"symptoms",
"(",
"i.e",
".",
"decrease",
"in",
"force",
"of",
"stream",
",",
"hesitancy",
",",
"intermittency",
",",
"post-void",
"dribbling",
")"
] |
[
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01184547
|
1:25:chronic_disease
|
Congestive heart failure
| 3
|
[
"Congestive",
"heart",
"failure"
] |
[
2,
2,
2
] |
NCT02874898
|
10:33:chronic_disease,
|
No clear trauma memory or trauma before age 3
| 3
|
[
"No",
"clear",
"trauma",
"memory",
"or",
"trauma",
"before",
"age",
"3"
] |
[
0,
0,
2,
2,
2,
2,
0,
0,
0
] |
NCT02453373
|
37:45:cancer,47:73:chronic_disease,78:86:chronic_disease
|
History of intracranial hemorrhage, neoplasm, arteriovenous malformation, or aneurysm
| 3
|
[
"History",
"of",
"intracranial",
"hemorrhage",
",",
"neoplasm",
",",
"arteriovenous",
"malformation",
",",
"or",
"aneurysm"
] |
[
0,
0,
0,
0,
0,
3,
0,
2,
2,
0,
0,
2
] |
NCT02982226
|
1:20:chronic_disease
|
Achilles tendonitis
| 3
|
[
"Achilles",
"tendonitis"
] |
[
2,
2
] |
NCT00147056
|
9:18:treatment
|
Cardiac pacemaker
| 3
|
[
"Cardiac",
"pacemaker"
] |
[
0,
1
] |
NCT03038269
|
21:45:chronic_disease
|
Previous episode of neurocardiogenic snycopy
| 3
|
[
"Previous",
"episode",
"of",
"neurocardiogenic",
"snycopy"
] |
[
0,
0,
0,
2,
2
] |
NCT02721303
|
1:21:chronic_disease
|
Cognitive impairment
| 3
|
[
"Cognitive",
"impairment"
] |
[
2,
2
] |
NCT01554410
|
13:31:allergy_name
|
Allergic to iodinated contrast if undergoing a contrast enhanced CT scan of the pelvis
| 3
|
[
"Allergic",
"to",
"iodinated",
"contrast",
"if",
"undergoing",
"a",
"contrast",
"enhanced",
"CT",
"scan",
"of",
"the",
"pelvis"
] |
[
0,
0,
4,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02536794
|
1:13:treatment,
|
radiotherapy within 2 weeks prior to entering the study
| 3
|
[
"radiotherapy",
"within",
"2",
"weeks",
"prior",
"to",
"entering",
"the",
"study"
] |
[
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03070145
|
15:18:treatment
|
Previously on ADT
| 3
|
[
"Previously",
"on",
"ADT"
] |
[
0,
0,
1
] |
NCT01873131
|
14:25:cancer
|
Infants with hemangiomas that threaten vital functions (e.g. obstructing the airway or impairing hearing or vision)
| 3
|
[
"Infants",
"with",
"hemangiomas",
"that",
"threaten",
"vital",
"functions",
"(",
"e.g",
".",
"obstructing",
"the",
"airway",
"or",
"impairing",
"hearing",
"or",
"vision",
")"
] |
[
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02543723
|
34:71:treatment
|
Patients who are on simultaneous oral and IV chemotherapeutic regimens
| 3
|
[
"Patients",
"who",
"are",
"on",
"simultaneous",
"oral",
"and",
"IV",
"chemotherapeutic",
"regimens"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
1,
1
] |
NCT01639508
|
,,115:137:treatment,139:151:treatment,153:177:treatment,182:204:treatment
|
Women of childbearing potential include women who have experienced menarche and who have not undergone successful surgical sterilization (hysterectomy, bilateral tubal ligation, or bilateral oophorectomy) or are not postmenopausal
| 3
|
[
"Women",
"of",
"childbearing",
"potential",
"include",
"women",
"who",
"have",
"experienced",
"menarche",
"and",
"who",
"have",
"not",
"undergone",
"successful",
"surgical",
"sterilization",
"(",
"hysterectomy",
",",
"bilateral",
"tubal",
"ligation",
",",
"or",
"bilateral",
"oophorectomy",
")",
"or",
"are",
"not",
"postmenopausal"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02107703
|
19:37:treatment,42:48:cancer,74:94:treatment,96:110:treatment,112:124:treatment,117:124:treatment,126:138:treatment,144:157:treatment,,184:207:treatment,,223:249:treatment,269:279:treatment,409:426:chronic_disease,430:451:chronic_disease
|
Have discontinued previous therapies for cancer (including specifically, aromatase inhibitors, anti-estrogens, chemotherapy, radiotherapy, and immunotherapy) for at least 21 days for myelosuppressive agents or 14 days for nonmyelosuppressive agents prior to receiving study drug, and recovered from the acute effects of therapy (until the toxicity resolves to either baseline or at least Grade 1) except for residual alopecia or peripheral neuropathy
| 3
|
[
"Have",
"discontinued",
"previous",
"therapies",
"for",
"cancer",
"(",
"including",
"specifically",
",",
"aromatase",
"inhibitors",
",",
"anti-estrogens",
",",
"chemotherapy",
",",
"radiotherapy",
",",
"and",
"immunotherapy",
")",
"for",
"at",
"least",
"21",
"days",
"for",
"myelosuppressive",
"agents",
"or",
"14",
"days",
"for",
"nonmyelosuppressive",
"agents",
"prior",
"to",
"receiving",
"study",
"drug",
",",
"and",
"recovered",
"from",
"the",
"acute",
"effects",
"of",
"therapy",
"(",
"until",
"the",
"toxicity",
"resolves",
"to",
"either",
"baseline",
"or",
"at",
"least",
"Grade",
"1",
")",
"except",
"for",
"residual",
"alopecia",
"or",
"peripheral",
"neuropathy"
] |
[
0,
0,
1,
1,
0,
3,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2
] |
NCT02072356
|
49:63:allergy_name,65:74:allergy_name,76:85:allergy_name,90:98:allergy_name
|
History of severe allergy or intolerance to any contrast media, narcotics, sedatives, or atropine that cannot be corrected or premedicated
| 3
|
[
"History",
"of",
"severe",
"allergy",
"or",
"intolerance",
"to",
"any",
"contrast",
"media",
",",
"narcotics",
",",
"sedatives",
",",
"or",
"atropine",
"that",
"can",
"not",
"be",
"corrected",
"or",
"premedicated"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
4,
4,
0,
4,
0,
4,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0
] |
NCT02101736
|
48:55:chronic_disease,76:94:treatment,,142:149:treatment
|
Other disorders associated with a high risk of fistula formation including PEG tube placement within 3 months before the first dose of study therapy
| 3
|
[
"Other",
"disorders",
"associated",
"with",
"a",
"high",
"risk",
"of",
"fistula",
"formation",
"including",
"PEG",
"tube",
"placement",
"within",
"3",
"months",
"before",
"the",
"first",
"dose",
"of",
"study",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02551679
|
1:16:chronic_disease
|
Hepatic failure
| 3
|
[
"Hepatic",
"failure"
] |
[
2,
2
] |
NCT02272998
|
1:38:chronic_disease
|
Psychiatric illness/social situations that would limit compliance with study requirements
| 3
|
[
"Psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01884740
|
1:16:treatment,
|
Minor surgeries may be performed after two weeks
| 3
|
[
"Minor",
"surgeries",
"may",
"be",
"performed",
"after",
"two",
"weeks"
] |
[
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02464878
|
5:17:chronic_disease,59:80:treatment,87:95:treatment,103:123:treatment,126:152:treatment
|
Any coagulopathy or medical condition requiring long-term anticoagulant therapy (e.g. warfarin) after islet transplantation (low-dose aspirin treatment [325 mg PO] is allowed)
| 3
|
[
"Any",
"coagulopathy",
"or",
"medical",
"condition",
"requiring",
"long-term",
"anticoagulant",
"therapy",
"(",
"e.g",
".",
"warfarin",
")",
"after",
"islet",
"transplantation",
"(",
"low-dose",
"aspirin",
"treatment",
"[",
"325",
"mg",
"PO",
"]",
"is",
"allowed",
")"
] |
[
0,
2,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
0,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02471430
|
12:35:treatment,
|
Use of any immunomodulatory agents within 30 days prior to study enrollment or planned use during the trial
| 3
|
[
"Use",
"of",
"any",
"immunomodulatory",
"agents",
"within",
"30",
"days",
"prior",
"to",
"study",
"enrollment",
"or",
"planned",
"use",
"during",
"the",
"trial"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02595372
|
1:23:treatment
|
bilateral oophorectomy
| 3
|
[
"bilateral",
"oophorectomy"
] |
[
1,
1
] |
NCT02291848
|
31:51:treatment,,115:127:treatment,129:140:treatment,142:154:treatment,165:186:treatment,195:200:treatment,208:212:treatment,213:229:treatment
|
Patients should have been off conventional therapy for at least 48 hours prior to entry in this study (except for lenalidomide, thalidomide, pomalidomide or immune checkpoint inhibitors such as CTLA4 and/or PD-1/PD-L1 inhibitors)
| 3
|
[
"Patients",
"should",
"have",
"been",
"off",
"conventional",
"therapy",
"for",
"at",
"least",
"48",
"hours",
"prior",
"to",
"entry",
"in",
"this",
"study",
"(",
"except",
"for",
"lenalidomide",
",",
"thalidomide",
",",
"pomalidomide",
"or",
"immune",
"checkpoint",
"inhibitors",
"such",
"as",
"CTLA4",
"and/or",
"PD-1/PD-L1",
"inhibitors",
")"
] |
[
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
0,
1,
1,
0,
0,
1,
0,
1,
1,
0
] |
NCT02828618
|
35:49:chronic_disease
|
Clinical relevant dysfunctions of blood clotting (including drug induced)
| 3
|
[
"Clinical",
"relevant",
"dysfunctions",
"of",
"blood",
"clotting",
"(",
"including",
"drug",
"induced",
")"
] |
[
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02423876
|
13:26:chronic_disease
|
Significant liver disease that would inhibit prescription of opioids
| 3
|
[
"Significant",
"liver",
"disease",
"that",
"would",
"inhibit",
"prescription",
"of",
"opioids"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02472834
|
8:26:chronic_disease
|
Severe hepatic impairment
| 3
|
[
"Severe",
"hepatic",
"impairment"
] |
[
0,
2,
2
] |
NCT02343042
|
1:31:chronic_disease,,
|
Congestive heart failure (CHF) of New York Heart Association (NYHA) Class ≥ 3
| 3
|
[
"Congestive",
"heart",
"failure",
"(",
"CHF",
")",
"of",
"New",
"York",
"Heart",
"Association",
"(",
"NYHA",
")",
"Class",
"≥",
"3"
] |
[
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03018418
|
27:75:cancer
|
Histologically documented squamous or basaloid carcinoma of the anal canal
| 3
|
[
"Histologically",
"documented",
"squamous",
"or",
"basaloid",
"carcinoma",
"of",
"the",
"anal",
"canal"
] |
[
0,
0,
3,
3,
3,
3,
3,
3,
3,
3
] |
NCT02635360
|
1:3:chronic_disease
|
TB
| 3
|
[
"TB"
] |
[
2
] |
NCT02240498
|
12:26:allergy_name,28:37:allergy_name,39:48:allergy_name,50:58:allergy_name,62:66:allergy_name
|
Allergy to contrast media, narcotics, sedatives, atropine or eggs
| 3
|
[
"Allergy",
"to",
"contrast",
"media",
",",
"narcotics",
",",
"sedatives",
",",
"atropine",
"or",
"eggs"
] |
[
0,
0,
4,
4,
0,
4,
0,
4,
0,
4,
0,
4
] |
NCT01880567
|
1:20:cancer,21:24:chronic_disease,,122:168:chronic_disease,170:186:chronic_disease,188:199:chronic_disease,,,
|
Relapsed/refractory MCL: Significant screening electrocardiogram (ECG) abnormalities including left bundle branch block, 2nd degree atrioventricular (AV) block type II, 3rd degree block, bradycardia (< 50 beats per minute [bpm]), or corrected QT (QTc) > 500 msec
| 3
|
[
"Relapsed/refractory",
"MCL",
":",
"Significant",
"screening",
"electrocardiogram",
"(",
"ECG",
")",
"abnormalities",
"including",
"left",
"bundle",
"branch",
"block",
",",
"2nd",
"degree",
"atrioventricular",
"(",
"AV",
")",
"block",
"type",
"II",
",",
"3rd",
"degree",
"block",
",",
"bradycardia",
"(",
"<",
"50",
"beats",
"per",
"minute",
"[",
"bpm",
"]",
")",
",",
"or",
"corrected",
"QT",
"(",
"QTc",
")",
">",
"500",
"msec"
] |
[
3,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02418195
|
36:57:treatment,99:111:treatment,120:128:treatment,141:154:treatment
|
Alcohol or drug dependence (except nicotine and caffeine) within the last month or the use of any hallucinogen (except cannabis), including phencyclidine in the last month
| 3
|
[
"Alcohol",
"or",
"drug",
"dependence",
"(",
"except",
"nicotine",
"and",
"caffeine",
")",
"within",
"the",
"last",
"month",
"or",
"the",
"use",
"of",
"any",
"hallucinogen",
"(",
"except",
"cannabis",
")",
",",
"including",
"phencyclidine",
"in",
"the",
"last",
"month"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02584647
|
77:93:chronic_disease,95:115:chronic_disease,129:153:chronic_disease,155:179:chronic_disease,181:199:chronic_disease,204:241:chronic_disease
|
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, active liver disease, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
| 3
|
[
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
",",
"active",
"liver",
"disease",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"or",
"psychiatric",
"illness/social",
"situations",
"that",
"would",
"limit",
"compliance",
"with",
"study",
"requirements"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02592707
|
29:62:treatment,
|
Administration of any other investigational medicinal product within 60 days prior to entry
| 3
|
[
"Administration",
"of",
"any",
"other",
"investigational",
"medicinal",
"product",
"within",
"60",
"days",
"prior",
"to",
"entry"
] |
[
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02064036
|
24:45:treatment
|
status-post a negative lymph node dissection are not eligible
| 3
|
[
"status-post",
"a",
"negative",
"lymph",
"node",
"dissection",
"are",
"not",
"eligible"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
0
] |
NCT02576431
|
29:51:treatment,74:79:cancer,233:257:treatment
|
Subjects must have received prior standard therapy appropriate for their tumor type and stage of disease, or in the opinion of the investigator, would be unlikely to tolerate or derive clinically meaningful benefit from appropriate standard of care therapy
| 3
|
[
"Subjects",
"must",
"have",
"received",
"prior",
"standard",
"therapy",
"appropriate",
"for",
"their",
"tumor",
"type",
"and",
"stage",
"of",
"disease",
",",
"or",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
",",
"would",
"be",
"unlikely",
"to",
"tolerate",
"or",
"derive",
"clinically",
"meaningful",
"benefit",
"from",
"appropriate",
"standard",
"of",
"care",
"therapy"
] |
[
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02640638
|
23:48:treatment,50:53:treatment,55:77:treatment
|
Any disease requiring chronic immunosuppression (SLE, solid organ transplant)
| 3
|
[
"Any",
"disease",
"requiring",
"chronic",
"immunosuppression",
"(",
"SLE",
",",
"solid",
"organ",
"transplant",
")"
] |
[
0,
0,
0,
1,
1,
0,
1,
0,
1,
1,
1,
0
] |
NCT01624090
|
1:17:treatment
|
Hepatic Function
| 3
|
[
"Hepatic",
"Function"
] |
[
1,
1
] |
NCT02921022
|
1:22:chronic_disease
|
metabolic dysfunction
| 3
|
[
"metabolic",
"dysfunction"
] |
[
2,
2
] |
NCT02339948
|
27:41:cancer
|
Histologically determined adenocarcinoma
| 3
|
[
"Histologically",
"determined",
"adenocarcinoma"
] |
[
0,
0,
3
] |
NCT03159936
|
66:74:treatment
|
Concomitant use of moderate to potent inhibitors and inducers of CYP3A4/5
| 3
|
[
"Concomitant",
"use",
"of",
"moderate",
"to",
"potent",
"inhibitors",
"and",
"inducers",
"of",
"CYP3A4/5"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02466750
|
10:41:treatment,,
|
Have WEE plaque reduction neutralization 80% titers (PRNT80) < 1:10 for primary series
| 3
|
[
"Have",
"WEE",
"plaque",
"reduction",
"neutralization",
"80",
"%",
"titers",
"(",
"PRNT80",
")",
"<",
"1:10",
"for",
"primary",
"series"
] |
[
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02615249
|
21:26:allergy_name
|
strong suspicion of metal contact allergy based on results of the Qualification Questionnaire
| 3
|
[
"strong",
"suspicion",
"of",
"metal",
"contact",
"allergy",
"based",
"on",
"results",
"of",
"the",
"Qualification",
"Questionnaire"
] |
[
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00909909
|
1:25:cancer
|
Ductal carcinoma in situ
| 3
|
[
"Ductal",
"carcinoma",
"in",
"situ"
] |
[
3,
3,
3,
3
] |
NCT02531932
|
1:14:chronic_disease,23:32:chronic_disease,34:58:chronic_disease,62:90:chronic_disease,122:135:chronic_disease
|
liver disease such as cirrhosis, chronic active hepatitis or chronic persistent hepatitis Note: A detailed assessment of Hepatitis B/C medical history and risk factors must be done at screening for all patients
| 3
|
[
"liver",
"disease",
"such",
"as",
"cirrhosis",
",",
"chronic",
"active",
"hepatitis",
"or",
"chronic",
"persistent",
"hepatitis",
"Note",
":",
"A",
"detailed",
"assessment",
"of",
"Hepatitis",
"B/C",
"medical",
"history",
"and",
"risk",
"factors",
"must",
"be",
"done",
"at",
"screening",
"for",
"all",
"patients"
] |
[
2,
2,
0,
0,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02843945
|
18:44:treatment
|
Patient Received neoadjuvant chemoradiation
| 3
|
[
"Patient",
"Received",
"neoadjuvant",
"chemoradiation"
] |
[
0,
0,
1,
1
] |
NCT01819480
|
1:19:cancer
|
Metastatic disease
| 3
|
[
"Metastatic",
"disease"
] |
[
3,
3
] |
NCT02969187
|
1:38:treatment
|
laparoscopic sleeve gastrectomy (LSG) as primary bariatric procedure
| 3
|
[
"laparoscopic",
"sleeve",
"gastrectomy",
"(",
"LSG",
")",
"as",
"primary",
"bariatric",
"procedure"
] |
[
1,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02347111
|
24:40:chronic_disease,,
|
congenital or acquired long QT syndrome with QTc>450 ms at baseline
| 3
|
[
"congenital",
"or",
"acquired",
"long",
"QT",
"syndrome",
"with",
"QTc",
">",
"450",
"ms",
"at",
"baseline"
] |
[
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.